The Gynecologic Oncology fellowship is a 3-year program that includes 1 year of research and 2 clinical years following completion of a 4 year residency program in Obstetrics and Gynecology. During training, the candidate masters the techniques of radical and minimally invasive pelvic surgery, administration of chemotherapy, coordination of radiation therapy, pain management and palliative care.
The Gynecologic Oncologist is trained to:
- Manage vaginal, intestinal, and urologic issues related to the care of gynecologic cancers and complicated benign gynecologic conditions.
- Deliver chemotherapy and coordinate its use in conjunction with surgical procedures and radiation therapy.
- Understand the principles of radiation therapy and integrate its place in the surgical and cytotoxic treatment of gynecologic malignancies.
- Perform Minimally Invasive Surgical (MIS) management of a growing variety of pelvic malignancies and complicated benign gynecologic diagnoses.
Helpful Information about the Novel Coronavirus (COVID-19) Hoag Gynecologic Oncology (HGO) continues to monitor the situation around the Coronavirus (COVID-19). Our top priority is the
Access to clinical trials. A prestigious designation in minimally invasive surgery. A dedicated gynecologic tumor board. A revamped system that is changing the way patients
“The most effective cure for breast and ovarian cancer is prevention, so ‘prevention’ is prominent in our program’s name because that is our mission and
Many people think eradicating cancer is an unattainable goal. But for cervical cancer, we are well on our way to doing just that. Cervical cancer